Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017170460) INFLAMMATORY INTESTINAL DISEASE THERAPEUTIC AGENT
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/170460 International Application No.: PCT/JP2017/012497
Publication Date: 05.10.2017 International Filing Date: 28.03.2017
IPC:
A61K 31/4172 (2006.01) ,A61P 1/04 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
4172
Imidazole-alkanecarboxylic acids, e.g. histidine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1
Drugs for disorders of the alimentary tract or the digestive system
04
for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applicants:
第一三共株式会社 DAIICHI SANKYO COMPANY,LIMITED [JP/JP]; 東京都中央区日本橋本町三丁目5番1号 3-5-1,Nihonbashi Honcho,Chuo-ku, Tokyo 1038426, JP
Inventors:
野口 研吾 NOGUCHI, Kengo; JP
伊藤 悠介 ITO, Yusuke; JP
Agent:
石橋 公樹 ISHIBASHI, Koki; JP
竹元 利泰 TAKEMOTO, Toshiyasu; JP
Priority Data:
2016-06499329.03.2016JP
Title (EN) INFLAMMATORY INTESTINAL DISEASE THERAPEUTIC AGENT
(FR) AGENT THÉRAPEUTIQUE CONTRE LES MALADIES INFLAMMATOIRES DE L'INTESTIN
(JA) 炎症性腸疾患治療剤
Abstract:
(EN) Provided is an inflammatory intestinal disease therapeutic agent that contains, as an active ingredient, a compound represented by formula (I) [in the formula, R is a hydrogen atom or a [1-(isobutyryloxy)ethoxy]carbonyl group or the like] or a pharmacologically acceptable salt thereof.
(FR) L'invention concerne un agent thérapeutique contre les maladies inflammatoires de l'intestin qui contient, en tant que principe actif, un composé représenté par la formule (I) [dans la formule, R représente un atome d'hydrogène ou un groupe [1-(isobutyryloxy)éthoxy]carbonyle ou similaire] ou un sel de qualité pharmacologique de celui-ci.
(JA) 式(I)[式中、Rは水素原子、又は[1-(イソブチリルオキシ)エトキシ]カルボニル基等を示す。]で表される化合物又はその薬理上許容される塩を有効成分として含有する炎症性腸疾患治療剤。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)